Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01351376 · ClinicalTrials.gov registry record · NA
LLLT Combined With CDT in Breast Cancer-Related Lymphedema
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01351376 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 21 participants.
The verdict
NCT01351376, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study aims to explore the effects of Low Level Laser Therapy (LLLT) on breast cancer-related lymphedema when utilized in conjunction with Complex Decongestive Therapy (CDT) when compared to CDT treatment alone. The investigators hypothesize that the addition of LLLT to CDT will result in statistically significant improvements and greater long-term benefits as measured by changes in arm volume and quality of life when compared to the benefits of CDT alone for the treatment of breast cancer-related lymphedema.
Interventions
- DEVICE Low Level Laser Therapy
- DEVICE Low Level Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2011-05 |
| Est. Completion | 2017-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01351376
The ClinicalTrials.gov registry entry for NCT01351376 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low Level Laser Therapy is the first listed.
NCT01351376 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01351376 about?
NCT01351376 is a clinical study titled "LLLT Combined With CDT in Breast Cancer-Related Lymphedema". This study aims to explore the effects of Low Level Laser Therapy (LLLT) on breast cancer-related lymphedema when utilized in conjunction with Complex Decongestive Therapy (CDT) when compared to CDT treatment alone. The investigators hypothesize that the addition of LLLT to CDT will result in statis...
What is the current status of trial NCT01351376?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2011-05. Estimated completion is 2017-07.
What interventions are being tested in trial NCT01351376?
The interventions under investigation include: Low Level Laser Therapy (DEVICE), Low Level Laser (DEVICE).
Who is sponsoring clinical trial NCT01351376?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.